ArticleVeterinary sciences2025
Inhibitory Effect of Transfer Factor on Avian Reticuloendotheliosis Virus Infection in Chicks.
Article in Veterinary sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Reticuloendotheliosis virus (REV) has multiple transmission routes and can induce severe immunosuppression upon infection. Three application scenarios were set up to explore transfer factor's (TF's) potential in controlling REV. These scenarios involved using TF in chicks infected with REV during incubation, in 1-day-old chicks post-infection, and in chicks prior to REV infection. The application value of TF in controlling REV was evaluated based on various indices, including weight gain, organ development, and virus replication. The results all indicate that the use of TF could effectively alleviate the developmental delay, hepatomegaly, and thymic atrophy caused by REV infection through different routes, as well as significantly reduce the mortality rate. It could also effectively inhibit REV replication in vivo and cloacal virus shedding. Notably, TF had apparent advantages in inhibiting cloacal virus shedding through the egg in the chicks infected with REV. The functions of TF are dose-dependent, where increasing the dose or frequency of use is beneficial for enhancing its effect. This study observed the role of TF in controlling REV infection under different application scenarios, providing necessary auxiliary means to reduce the harm of REV infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.